Blackstone Completes $14.6 Billion Recapitalization of BioMed Realty
2020年11月21日 - 02:15AM
ビジネスワイヤ(英語)
Blackstone (NYSE: BX) today announced that Blackstone Real
Estate Partners VIII L.P. and co-investors have completed their
previously announced transaction to sell BioMed Realty for $14.6
billion to a group led by existing BioMed investors. This
transaction is part of a new long-term, perpetual capital, core+
return strategy managed by Blackstone.
Morgan Stanley & Co. LLC served as financial advisor to BREP
VIII and completed a “go-shop” process on behalf of BioMed’s
selling investors.
Citigroup Global Markets Inc., Deutsche Bank Securities Inc.,
Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells
Fargo Securities LLC also served as financial advisors to BREP
VIII, and Eastdil Secured served as financial advisor to the
purchasers. Simpson Thacher & Bartlett LLP served as legal
advisor to Blackstone.
The transaction was announced on October 15, 2020.
About Blackstone Real Estate
Blackstone is a global leader in real estate investing.
Blackstone’s real estate business was founded in 1991 and has $174
billion of investor capital under management. Blackstone is one of
the largest property owners in the world, owning and operating
assets across every major geography and sector, including
logistics, multifamily and single-family housing, office,
hospitality and retail. Our opportunistic funds seek to acquire
undermanaged, well-located assets across the world. Blackstone’s
Core+ strategy invests in substantially stabilized real estate
globally through regional open-ended funds focused on high-quality
assets and Blackstone Real Estate Income Trust, Inc. (BREIT), a
non-listed REIT that invests in U.S. income-generating assets.
Blackstone Real Estate also operates one of the leading global real
estate debt businesses, providing comprehensive financing solutions
across the capital structure and risk spectrum, including
management of Blackstone Mortgage Trust (NYSE: BXMT).
About BioMed Realty
BioMed Realty, a Blackstone portfolio company, is the largest
private provider of real estate solutions to the life science and
technology industries. BioMed owns and operates high quality life
science real estate comprising 11.3 million square feet
concentrated in the leading innovation markets throughout the
United States and United Kingdom, including Boston/Cambridge, San
Francisco, San Diego, Seattle and Cambridge U.K. In addition,
BioMed maintains a premier development platform with 2.3 million
square feet of Class A properties in active construction to meet
the growing demand of the life science industry.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201120005623/en/
Ilana Mouritzen Ilana.Mouritzen@Blackstone.com Tel: (212)
583-5776
Blackstone (NYSE:BX)
過去 株価チャート
から 2 2024 まで 3 2024
Blackstone (NYSE:BX)
過去 株価チャート
から 3 2023 まで 3 2024